For the Inventor, By the Inventor

Enter assignee name

Framingham, MA, United States of America

Berg LLC

USPTO Granted Patents = 37

% Expired Patents = 13.5

CIPO Patents = 7

EPO Patents = 15

Trademarks = 7

Forward Citations = 126

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Niven Rajin Narain (34 out of 51 patents)

Rangaprasad Sarangarajan (24 out of 30 patents)

John Patrick McCook (14 out of 25 patents)

4. Vivek Kannoth Vishnudas (14 out of 14 patents)

5. Joaquin J Jimenez (6 out of 15 patents)

6. Enxuan Jing (5 out of 5 patents)

7. Stephane Gesta (4 out of 4 patents)

8. Nikunj Narendra Tanna (4 out of 4 patents)

9. Shen Luan (3 out of 3 patents)

10. Viatcheslav R Akmaev (3 out of 13 patents)

11. Indushekhar Persaud (3 out of 10 patents)

12. Michael Andrew Kiebish (3 out of 6 patents)

13. Thomas Mitchell Gray (2 out of 4 patents)

14. Dinesh U Chimmanamada (1 out of 46 patents)

15. Paula Patricia Narain (1 out of 1 patent)

Core Competencies:

Drug-Induced Toxicity

Biomarkers

Coenzyme Q10

Cancer Treatment

Apoptosis Induction

Parkinson's Disease

Inhalable Formulations

Metabolic Syndrome

Filamin A

Stress-Induced Disorders

Tumor Prevention

Healthcare Diagnosis

37 patents: Sort by Forward Citations

1. 11694765 - Interrogatory cell-based assays for identifying drug-induced toxicity markers (2023-07-04),

2. 11622948 - Biomarkers for efficacy of prophylactic treatments against stress-induced affective disorders (2023-04-11),

3. 11456054 - Interrogatory cell-based assays and uses thereof (2022-09-27),

4. 11452699 - Method of treating or preventing tumors of the central nervous system (2022-09-27),

5. 11419830 - Use of coenzyme Q10 formulations in the treatment and prevention of epidermolysis bullosa (2022-08-23),

6. 11400058 - Intravenous formulations of coenzyme Q10 (CoQ10) and methods of use thereof (2022-08-02),

7. 11305016 - Vitamin D3 and analogs thereof for treating alopecia (2022-04-19),

8. 11298313 - Methods of treatment of cancer by continuous infusion of coenzyme Q10 (2022-04-12),

9. 11224641 - Enolase 1 (ENO1) compositions and uses thereof (2022-01-18),

10. 11209422 - Methods and kits for detection of coenzyme Q10 (2021-12-28),

11. 11091447 - UBE2K modulators and methods for their use (2021-08-17),

12. 11028446 - Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme Q10) (2021-06-08),

13. 11001891 - Methods for treating Parkinson's disease (2021-05-11),

14. 10973763 - Inhalable pharmaceutical compositions (2021-04-13),

15. 10933032 - Methods for the treatment of cancer using coenzyme Q10 combination therapies (2021-03-02),

Company Overview

Berg LLC is a biotechnology company based in Framingham, MA, specializing in the development of innovative solutions in the fields of healthcare and life sciences. The organization focuses on leveraging advanced technologies, including artificial intelligence and data analytics, to enhance drug discovery and personalized medicine. By integrating biological insights with computational methods, Berg aims to address complex health challenges and improve patient outcomes through targeted therapeutic strategies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

37 Patents

#7 in Framingham, MA

#540 in Massachusetts

#9,270 in US

#18,299 in the World

Framingham, MA, United States of America

Berg LLC

Forward Citations = 126

26 inventors:

Niven Rajin Narain (34 out of 51 patents)

Rangaprasad Sarangarajan (24 out of 30 patents)

John Patrick McCook (14 out of 25 patents)

4. Vivek Kannoth Vishnudas (14 out of 14 patents)

5. Joaquin J Jimenez (6 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Berg LLC. Retrieved from https://idiyas.com/company/berg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…